Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Chest	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
w/	O
a-fib	O
on	O
Xarelto,	O
HTN,	O
HLD,	O
obesity,	O
COPD,	O
SCC	O
of	O
the	O
base	O
of	O
the	O
tongue	O
(s/p	O
chemotherapy	O
and	O
XRT	O
in	O
___,	O
and	O
dysphagia,	O
who	O
presented	O
with	O
chest	O
pain	O
in	O
the	O
setting	O
of	O
a-fib	O
with	O
RVR.	O
Of	O
note,	O
somewhat	O
limited	O
records	O
are	O
available.	O
The	O
patient's	O
care	O
is	O
primarily	O
through	O
___	O
for	O
the	O
Homeless	O
with	O
his	O
specialty	O
and	O
inpatient	O
care	O
mostly	O
at	O
___.	O
He	O
also	O
an	O
admission	O
to	O
___	O
earlier	O
this	O
month	O
where	O
he	O
reportedly	O
was	O
intubated.	O
His	O
most	O
recent	O
available	O
medication	O
list	O
pre-dates	O
his	O
last	O
PCP	O
visit	O
and	O
also	O
his	O
most	O
recent	O
admission;	O
his	O
recent	O
pharmacy	O
refills	O
are	O
not	O
in	O
close	O
agreement	O
with	O
the	O
available	O
list.	O
Of	O
particular	O
interest	O
is	O
that	O
his	O
Toprol	O
dose	O
was	O
previously	O
200	O
mg	O
daily	O
but	O
this	O
seems	O
to	O
have	O
been	O
reduced	O
to	O
50	O
mg	O
daily	O
and	O
has	O
no	O
recent	O
refills.	O
He	O
also	O
was	O
on	O
digoxin	O
previously,	O
but	O
this	O
does	O
not	O
seem	O
to	O
have	O
been	O
refilled.	O
Records	O
have	O
been	O
requested	O
from	O
___;	O
___	O
___	O
and	O
___	O
medical	O
records	O
departments	O
were	O
not	O
reachable	O
overnight.	O
At	O
3	O
___	O
on	O
day	O
of	O
presentation,	O
he	O
had	O
onset	O
of	O
constant	O
substernal	O
chest	O
pressure	O
radiating	O
to	O
his	O
back.	O
The	O
pain	O
was	O
associated	O
with	O
mild	O
dyspnea	O
and	O
palpitations.	O
He	O
called	O
EMS	O
who	O
found	O
him	O
to	O
be	O
in	O
a-fib	O
with	O
rates	O
in	O
the	O
160s.	O
He	O
was	O
given	O
20	O
mg	O
IV	O
diltiazem	O
and	O
brought	O
to	O
___.	O
The	O
patient	O
remained	O
appropriately	O
rate-controlled	O
on	O
arrival	O
to	O
the	O
ED;	O
vitals	O
were:	O
97.8F,	O
HR	O
90-110,	O
BP	O
142/86,	O
RR	O
18,	O
96%	O
RA.	O
Labs	O
were	O
notable	O
for	O
WBC	O
14.2	O
(92%	O
polys),	O
Na	O
128,	O
and	O
negative	O
troponin.	O
EKG	O
showed	O
ST	O
depressions	O
and	O
T	O
wave	O
inversions	O
in	O
lateral	O
leads.	O
He	O
was	O
given	O
ASA	O
325	O
mg	O
and	O
sublingual	O
nitro.	O
CXR	O
and	O
CTPA	O
were	O
both	O
potentially	O
suggestive	O
of	O
pneumonia	B-Lower_respiratory_tract_infection
so	O
blood	O
cultures	O
x2	O
were	O
collected	O
and	O
he	O
was	O
given	O
cefepime	O
2g	O
for	O
possible	O
HAP.	B-Lower_respiratory_tract_infection
He	O
was	O
admitted	O
to	O
medicine	O
for	O
further	O
workup	O
and	O
management.	O
REVIEW	O
OF	O
SYSTEMS	O
GEN:	O
denies	O
fevers/chills	O
CARDIAC:	O
as	O
per	O
HPI.	O
PULM:	O
denies	O
new	O
dyspnea	O
or	O
cough	O
GI:	O
denies	O
n/v,	O
denies	O
change	O
in	O
bowel	O
habits	O
GU:	O
denies	O
dysuria	O
or	O
change	O
in	O
appearance	O
of	O
urine	O
Full	O
14-system	O
review	O
of	O
systems	O
otherwise	O
negative	O
and	O
non-contributory.	O
Past	O
Medical	O
History:	O
A-fib	O
(on	O
Xarelto;	O
sees	O
a	O
cardiologist	O
at	O
___)	O
History	O
of	O
VTE,	O
per	O
patient	O
HTN	O
HLD	O
COPD	O
Pneumonia	B-Lower_respiratory_tract_infection
SCC	O
of	O
the	O
base	O
of	O
the	O
tongue	O
(s/p	O
chemotherapy	O
and	O
XRT	O
in	O
___	O
followed	O
at	O
___)	O
Dysphagia	O
(on	O
soft	O
diet)	O
Malnutrition	B-Malnutrition
Hypothyroidism	O
Mood	O
disorder	O
anxiety	O
Urinary	O
frequency	O
Hydrocele	O
Constipation	B-Constipation
Insomnia	O
___	O
esophagus	O
Remote	O
esophageal	O
ulcer	O
S/p	O
cholecystectomy.	O
Inguinal	O
hernia.	O
Umbilical	O
hernia.	O
Remote	O
MVC	O
with	O
multiple	O
fractures	O
Postherpetic	O
neuralgia.	O
PPD	O
positive	O
in	O
___	O
Pulmonary	O
nodule	O
(stable)	O
Sciatica	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
colon	O
cancer.	O
No	O
family	O
history	O
of	O
early	O
CAD.	O
Physical	O
Exam:	O
Admission	O
Exam:	O
VITALS:	O
last	O
24-hour	O
vitals	O
were	O
reviewed.	O
GEN:	O
thin,	O
disheveled	O
man	O
in	O
NAD	O
EYE:	O
anicteric	O
ENT:	O
dry	O
mouth,	O
no	O
thrush	O
LYMPHATIC:	O
No	O
LAD	O
CARDIAC:	O
irregularly	O
irregular,	O
normal	O
rate,	O
no	O
M/R/G	O
appreciated.	O
JVP	O
not	O
elevated.	O
PULM:	O
normal	O
effort,	O
no	O
accessory	O
muscle	O
use,	O
no	O
wheezes,	O
no	O
rales	O
GI:	O
soft,	O
NT,	O
ND,	O
NABS	O
DERM:	O
No	O
visible	O
rash.	O
No	O
jaundice.	O
NEURO:	O
AAOx3.	B-Delirium
No	O
facial	O
droop,	O
moving	O
all	O
extremities.	O
PSYCH:	O
Full	O
range	O
of	O
affect	O
DERM:	O
WWP,	O
no	O
edema,	O
poor	O
skin	O
turgor	O
Discharge	O
Exam:	O
VS:	O
98.9	O
101	O
119/80	O
20	O
96%RA	O
General:	O
Well	O
appearing,	O
sitting	O
up	O
in	O
bed	O
in	O
NAD	O
Eyes:	O
PERLL,	O
EOMI,	O
sclera	O
anicteric	O
ENT:	O
MMM,	O
oropharynx	O
clear	O
without	O
exudate	O
or	O
lesions	O
Respiratory:	O
CTAB	O
without	O
crackles,	O
wheeze,	O
rhonchi.	O
Cardiovascular:	O
Irregularly	O
irregular	O
rhythm,	O
normal	O
S1	O
and	O
S2,	O
no	O
murmurs,	O
rubs	O
or	O
gallops	O
Gastrointestinal:	O
Soft,	O
nontender,	O
nondistended,	O
+BS,	O
no	O
masses	O
or	O
HSM	O
Extremities:	O
Warm	O
and	O
well	O
perfused,	O
no	O
peripheral	O
edema	O
Skin:	O
warm,	O
no	O
rashes/no	O
jaundice/no	O
skin	O
ulcerations	O
noted	O
Neurological:	O
Alert	O
and	O
oriented	B-Delirium
x3,	B-Delirium
motor	O
and	O
sensory	O
exam	O
grossly	O
intact	O
Psych:	O
Affect	O
flat,	O
mood	O
anxious	O
Pertinent	O
Results:	O
***************	O
ADMISSION	O
LABS	O
***************	O
___	O
01:40AM	O
NEUTS-92.4*	O
LYMPHS-3.4*	O
MONOS-3.6*	O
EOS-0.0*	O
BASOS-0.1	O
IM	O
___	O
AbsNeut-13.09*#	O
AbsLymp-0.48*	O
AbsMono-0.51	O
AbsEos-0.00*	O
AbsBaso-0.01	O
___	O
01:40AM	O
WBC-14.2*#	O
RBC-4.27*	O
HGB-12.8*	O
HCT-37.3*	O
MCV-87#	O
MCH-30.0	O
MCHC-34.3	O
RDW-14.1	O
RDWSD-45.2	O
___	O
01:40AM	O
CALCIUM-8.3*	O
PHOSPHATE-2.3*	O
MAGNESIUM-1.9	O
___	O
01:40AM	O
cTropnT-<0.01	O
___	O
01:40AM	O
estGFR-Using	O
this	O
___	O
01:40AM	O
GLUCOSE-102*	O
UREA	O
N-8	O
CREAT-0.3*	O
SODIUM-128*	O
POTASSIUM-3.5	O
CHLORIDE-90*	O
TOTAL	O
CO2-27	O
ANION	O
GAP-15	O
___	O
01:50AM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-7.0	O
LEUK-NEG	O
___	O
01:50AM	O
URINE	O
COLOR-Straw	O
APPEAR-Clear	O
SP	O
___	O
___	O
01:50AM	O
LACTATE-2.0	O
___	O
01:50AM	O
URINE	O
UHOLD-HOLD	O
___	O
04:00AM	O
OTHER	O
BODY	O
FLUID	O
FluAPCR-NEGATIVE	O
FluBPCR-NEGATIVE	O
___	O
05:51AM	O
PLT	O
COUNT-198	O
___	O
05:51AM	O
WBC-12.3*	O
RBC-4.09*	O
HGB-12.5*	O
HCT-36.1*	O
MCV-88	O
MCH-30.6	O
MCHC-34.6	O
RDW-14.0	O
RDWSD-45.0	O
___	O
05:51AM	O
cTropnT-<0.01	O
___	O
05:51AM	O
GLUCOSE-84	O
UREA	O
N-7	O
CREAT-0.4*	O
SODIUM-132*	O
POTASSIUM-3.3	O
CHLORIDE-93*	O
TOTAL	O
CO2-31	O
ANION	O
GAP-11	O
*****************	O
DISCHARGE	O
LABS:	O
*****************	O
___	O
05:28AM	O
BLOOD	O
WBC-12.3*	O
RBC-4.00*	O
Hgb-12.0*	O
Hct-35.1*	O
MCV-88	O
MCH-30.0	O
MCHC-34.2	O
RDW-14.2	O
RDWSD-45.9	O
Plt	O
___	O
___	O
05:28AM	O
BLOOD	O
Glucose-83	O
UreaN-10	O
Creat-0.5	O
Na-129*	O
K-4.4	O
Cl-91*	O
HCO3-29	O
AnGap-13	O
___	O
05:51AM	O
BLOOD	O
cTropnT-<0.01	O
___	O
07:30PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
05:28AM	O
BLOOD	O
Calcium-8.2*	O
Phos-3.4	O
Mg-1.9	O
***************	O
STUDIES	O
&	O
IMAGING	O
***************	O
EKG	O
___	O
a-fib.	O
TWI	O
and	O
STD	O
laterally	O
new	O
from	O
prior	O
CXR	O
___	O
1.	O
Bibasilar	O
opacities,	O
left	O
greater	O
than	O
right,	O
may	O
represent	O
atelectasis.	O
However,	O
concurrent	O
pneumonia	B-Lower_respiratory_tract_infection
is	O
difficult	O
to	O
exclude	O
in	O
the	O
appropriate	O
clinical	O
setting.	O
2.	O
Bilateral	O
small	O
pleural	O
effusions.	O
3.	O
Emphysematous	O
changes	O
are	O
redemonstrated.	O
4.	O
R-sided	O
port-a-cath	O
CTPA	O
___	O
1.	O
No	O
evidence	O
of	O
pulmonary	O
embolism	O
or	O
aortic	O
abnormality.	O
2.	O
___	O
opacities	O
are	O
seen	O
in	O
the	O
left	O
upper	O
lobe	B-Lower_respiratory_tract_infection
with	O
associated	O
atelectasis,	O
which	O
can	O
be	O
concerning	O
for	O
developing	O
infection.	B-Lower_respiratory_tract_infection
3.	O
The	O
main	O
pulmonary	O
artery	O
is	O
enlarged,	O
measuring	O
up	O
to	O
3.3	O
cm,	O
which	O
can	O
be	O
seen	O
in	O
pulmonary	O
hypertension.	O
4.	O
Moderate	O
diffuse	O
centrilobular	O
emphysema.	O
5.	O
Stable	O
cortical	O
deformities	O
of	O
the	O
right	O
___	O
ribs,	O
left	O
___	O
ribs,	O
and	O
sternum	O
since	O
___.	O
6.	O
Stable	O
appearance	O
of	O
a	O
2-3	O
mm	O
pulmonary	O
nodule	O
in	O
the	O
right	O
upper	O
lobe	O
since	O
___.	O
MICRO:	O
___	O
legionella	O
urine	O
ag	O
neg	O
___	O
MRSA	O
screen	O
positive	O
___	O
Bcx	O
x2	O
pending	O
___	O
Ucx	O
final	O
Brief	O
Hospital	O
Course:	O
___	O
y/o	O
male	O
with	O
hx	O
of	O
a	O
recent	O
hospitalization	O
and	O
ICU	O
stay	O
for	O
apparent	O
aspiration	O
pneumonia	B-Lower_respiratory_tract_infection
at	O
___	O
who	O
left	O
his	O
SNF	O
AMA,	O
p/w	O
chest	O
pain	O
and	O
found	O
to	O
have	O
Afib	O
with	O
RVR.	O
#	O
Afib	O
with	O
RVR/chest	O
pain:	O
Chronic,	O
CHADS2VASC=4.	O
Exacerbation	O
likely	O
from	O
missing	O
meds	O
after	O
leaving	O
AMA	O
from	O
rehab.	O
Well	O
controlled	O
on	O
regimen	O
of	O
Lopressor	O
25	O
TID	O
and	O
digoxin	O
0.25	O
mg	O
daily	O
at	O
___,	O
did	O
well	O
at	O
___	O
on	O
50mg	O
TID	O
metoprolol	O
tartrate.	O
EKG	O
without	O
evidence	O
of	O
acute	O
change	O
or	O
ischemia,	O
recent	O
troponins	O
flat	O
making	O
ischemia	O
unlikely.	O
Triggered	O
for	O
chest	O
pain	O
and	O
RVR	O
on	O
night	O
prior	O
to	O
admission	O
in	O
the	O
setting	O
of	O
50mg	O
tartrate	O
and	O
100mg	O
succinate	O
in	O
AM,	O
HR	O
responded	O
well	O
to	O
5mg	O
IV	O
metoprolol.	O
Continued	O
to	O
have	O
some	O
pain,	O
trops	O
negative,	O
nitro	O
did	O
not	O
help,	O
EKG	O
unchanged.	O
Given	O
low	O
dose	O
morphine	O
x1	O
with	O
improvement.	O
No	O
pain	O
on	O
day	O
of	O
discharge,	O
HR	O
stable	O
during	O
day	O
on	O
150mg	O
succinate.	O
Continued	O
rivaroxaban	O
for	O
anticoagulation.	O
#	O
Aspiration	O
pneumonia:	B-Lower_respiratory_tract_infection
Treated	O
at	O
___	O
for	O
significant	O
aspiration	O
pneumonia.	B-Lower_respiratory_tract_infection
Given	O
that	O
he	O
likely	O
missed	O
___	O
days	O
of	O
clindamycin	O
after	O
AMA	O
from	O
rehab,	O
continued	O
course	O
until	O
___.	O
No	O
sx	O
at	O
discharge.	O
#	O
Delirium/anxiety:	B-Delirium
He	O
was	O
found	O
to	O
have	O
delirium	B-Delirium
and	O
post-traumatic	O
stress	O
symptoms	O
after	O
his	O
ICU	O
stay.	O
He	O
may	O
have	O
underlying	O
cognitive	B-Unspecified_cognitive_impairment
impairment	B-Unspecified_cognitive_impairment
but	O
this	O
could	O
not	O
be	O
assessed	O
in	O
the	O
setting	O
of	O
active	O
delirium.	B-Delirium
It	O
was	O
unclear	O
if	O
he	O
could	O
able	O
to	O
manage	O
his	O
outpatient	O
medication	O
regimen	O
at	O
this	O
time,	O
and	O
was	O
discharged	O
from	O
___	O
on	O
18	O
meds	O
with	O
multiple	O
frequencies	O
of	O
administration.	O
It	O
is	O
also	O
notable	O
that	O
the	O
one	O
medication	O
he	O
does	O
remember	O
is	O
Ativan-	O
on	O
discussion	O
with	O
patient	O
and	O
review	O
of	O
___,	O
he	O
has	O
been	O
on	O
Ativan	O
for	O
some	O
time	O
and	O
was	O
previously	O
on	O
temazepam	O
6	O
months	O
ago.	O
His	O
most	O
recent	O
standing	O
dose	O
was	O
0.5mg	O
QID.	O
He	O
frequently	O
requested	O
higher	O
doses	O
of	O
Ativan	O
and	O
temazepam	O
and	O
frequently	O
noted	O
anxiety	O
as	O
a	O
major	O
issue.	O
Would	O
like	O
to	O
wean	O
lorazepam,	O
but	O
patient	O
is	O
adamant	O
about	O
keeping	O
it,	O
noting	O
that	O
he	O
would	O
buy	O
it	O
on	O
the	O
street	O
as	O
his	O
anxiety	O
is	O
so	O
bad.	O
He	O
also	O
expresses	O
a	O
feeling	O
that	O
he	O
will	O
die	O
and	O
does	O
not	O
want	O
to	O
die	O
in	O
a	O
hospital.	O
He	O
threatened	O
to	O
leave	O
AMA	O
several	O
times	O
unless	O
he	O
was	O
given	O
IV	O
morphine.	O
His	O
behavior	O
is	O
somewhat	O
concerning	O
for	O
abuse	O
and	O
he	O
was	O
not	O
provided	O
with	O
a	O
rx	O
on	O
discharge,	O
given	O
recent	O
rx	O
from	O
other	O
institutions.	O
Delirium	B-Delirium
improved	O
prior	O
to	O
discharge.	O
___	O
and	O
OT	O
recommended	O
rehab	O
but	O
patient	O
decided	O
to	O
leave	O
AMA,	O
elucidated	O
that	O
he	O
is	O
at	O
risk	O
to	O
fall,	B-Falls
that	O
he	O
will	O
stay	O
with	O
friends,	O
and	O
that	O
he	O
understands	O
he	O
is	O
strongly	O
advised	O
to	O
go	O
to	O
rehab	O
and	O
follow	O
with	O
a	O
PCP	O
for	O
multiple	O
medical	O
issues	O
but	O
still	O
chooses	O
to	O
leave.	O
#Dry	O
mouth/mouth	O
pain:	O
___	O
ENT	O
cancer	O
tx.	O
Chronic	O
issue,	O
started	O
caphosol	O
(artificial	O
saliva).	O
Received	O
magic	O
mouthwash	O
in	O
house.	O
#Hyponatremia:	O
Na	O
fluctuated	O
between	O
128-132.	O
Unclear	O
baseline.	O
Unclear	O
etiology,	O
likely	O
not	O
SIADH	O
despite	O
lung	O
pathology	O
as	O
Na	O
slightly	O
decreased	O
with	O
1500cc	O
fluid	O
restriction,	O
though	O
unclear	O
if	O
patient	O
actually	O
kept	O
this	O
strictly.	O
Administer	O
fluid	O
to	O
test	O
for	O
hypovolemia,	O
but	O
left	O
AMA	O
prior	O
to	O
repeat	O
Na	O
testing.	O
#Leukocytosis:	O
WBC	O
15,	O
slightly	O
elevated	O
but	O
largely	O
stable	O
over	O
several	O
days,	O
improved	O
to	O
12.3	O
on	O
day	O
of	O
discharge.	O
Likely	O
related	O
to	O
known	O
aspiration	O
pneumonia.	B-Lower_respiratory_tract_infection
#Chronic	O
systolic	O
congestive	O
heart	O
failure:	O
Stable	O
in	O
house,	O
discharged	O
on	O
home	O
meds.	O
#Hx	O
of	O
tonsillar	O
cancer:	O
Treated	O
in	O
___,	O
port	O
still	O
in	O
place	O
with	O
plans	O
to	O
remove	O
as	O
outpatient	O
but	O
patient	O
did	O
not	O
follow	O
up.	O
Will	O
need	O
follow	O
up	O
for	O
this.	O
Transitional	O
issues:	O
-Hx	O
of	O
head	O
and	O
neck	O
cancer	O
treated	O
in	O
___	O
by	O
Dr.	O
___	O
follow	O
by	O
Dr.	O
___	O
at	O
___,	O
has	O
not	O
kept	O
prescribed	O
follow	O
up	O
(last	O
appointment	O
almost	O
___	O
year	O
ago).	O
Will	O
need	O
onc	O
follow	O
up	O
and	O
will	O
need	O
port	O
removed,	O
___	O
previously	O
contacted	O
as	O
outpatient.	O
-Found	O
to	O
have	O
8mm	O
lung	O
nodule	O
on	O
Chest	O
CT,	O
will	O
need	O
follow	O
up	O
Chest	O
CT	O
in	O
___	O
months,	O
___	O
months,	O
and	O
24	O
months.	O
PCP	O
mailed	O
___	O
letter	O
regarding	O
this	O
and	O
patient	O
informed.	O
-Discharged	O
on	O
150mg	O
metoprolol	O
succinate	O
-Patient	O
is	O
homeless,	O
would	O
benefit	O
from	O
social	O
services	O
intervention	O
-Avoid	O
diltiazem	O
given	O
?history	O
of	O
angioedema	O
-Consider	O
restart	O
digoxin	O
if	O
Afib	O
with	O
RVR	O
recurs	O
>30	O
min	O
spent	O
on	O
discharge	O
coordination	O
on	O
day	O
of	O
discharge	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Rivaroxaban	O
20	O
mg	O
PO	O
DAILY	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
4.	O
Fluticasone	O
Propionate	O
110mcg	O
2	O
PUFF	O
IH	O
BID	O
5.	O
umeclidinium	O
62.5	O
mcg/actuation	O
inhalation	O
DAILY	O
6.	O
DULoxetine	O
60	O
mg	O
PO	O
DAILY	O
7.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY	O
anxiety	O
8.	O
PARoxetine	O
20	O
mg	O
PO	O
DAILY	O
9.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
10.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
11.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q2H:PRN	O
wheezing	O
12.	O
Clindamycin	O
300	O
mg	O
PO	O
Q6H	O
13.	O
Digoxin	O
0.25	O
mg	O
PO	O
DAILY	O
14.	O
LORazepam	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia/anxiety	O
15.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
DAILY	O
16.	O
melatonin	O
3	O
mg	O
oral	O
QHS	O
17.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
TID	O
18.	O
PredniSONE	O
40	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
dyspnea	O
RX	O
*albuterol	O
sulfate	O
[Ventolin	O
HFA]	O
90	O
mcg	O
2	O
puffs	O
inh	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*1	O
Inhaler	O
Refills:*0	O
2.	O
Caphosol	O
30	O
mL	O
ORAL	O
QID	O
RX	O
*saliva	O
substitute	O
combo	O
no.2	O
Use	O
30	O
mL	O
four	O
times	O
a	O
day	O
Disp	O
___	O
Milliliter	O
Refills:*0	O
3.	O
Metoprolol	O
Succinate	O
XL	O
150	O
mg	O
PO	O
DAILY	O
RX	O
*metoprolol	O
succinate	O
100	O
mg	O
1.5	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
6.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
7.	O
DULoxetine	O
60	O
mg	O
PO	O
DAILY	O
8.	O
Fluticasone	O
Propionate	O
110mcg	O
2	O
PUFF	O
IH	O
BID	O
9.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY	O
anxiety	O
10.	O
LORazepam	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia/anxiety	O
11.	O
Losartan	O
Potassium	O
25	O
mg	O
PO	O
DAILY	O
12.	O
melatonin	O
3	O
mg	O
oral	O
QHS	O
13.	O
PARoxetine	O
20	O
mg	O
PO	O
DAILY	O
14.	O
Rivaroxaban	O
20	O
mg	O
PO	O
DAILY	O
15.	O
umeclidinium	O
62.5	O
mcg/actuation	O
inhalation	O
DAILY	O
16.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
Atrial	O
fibrillation,	O
atypical	O
chest	O
pain	O
Secondary:	O
Aspiration	O
pneumonia,	B-Lower_respiratory_tract_infection
delirium,	B-Delirium
dry	O
mouth,	O
anxiety,	O
hyponatremia,	O
lung	O
nodule,	O
chronic	O
systolic	O
congestive	O
heart	O
failure	O
Discharge	O
Condition:	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
admitted	O
to	O
___	O
with	O
fast	O
heart	O
rate	O
due	O
to	O
an	O
abnormal	O
but	O
common	O
heart	O
rhythm	O
called	O
atrial	O
fibrillation,	O
which	O
you	O
have	O
had	O
before.	O
Your	O
medication	O
was	O
adjusted	O
which	O
helped	O
your	O
symptoms,	O
and	O
your	O
chest	O
pain	O
is	O
not	O
from	O
a	O
heart	O
attack	O
but	O
most	O
likely	O
related	O
to	O
the	O
fast	O
heart	O
beat.	O
You	O
were	O
found	O
to	O
have	O
mildly	O
low	O
sodium	O
levels	O
in	O
your	O
blood	O
which	O
may	O
be	O
from	O
being	O
a	O
bit	O
dehydrated.	O
You	O
were	O
seen	O
by	O
physical	O
and	O
occupational	O
therapy	O
who	O
felt	O
you	O
would	O
benefit	O
from	O
rehab,	O
but	O
you	O
decided	O
to	O
leave	O
the	O
hospital	O
against	O
medical	O
advice.	O
You	O
expressed	O
that	O
you	O
understand	O
the	O
risks	O
of	O
falling	B-Falls
and	O
injuring	O
your	O
self.	O
You	O
completed	O
antibiotics	O
for	O
pneumonia	B-Lower_respiratory_tract_infection
on	O
___.	O
I	O
strongly	O
advise	O
that	O
you	O
see	O
your	O
primary	O
care	O
doctor	O
for	O
follow	O
up	O
of	O
various	O
issues,	O
including	O
lung	O
nodules	O
that	O
need	O
follow	O
up	O
in	O
three	O
months.	O
Best	O
of	O
luck,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

